DOI: 10.1097/01.OTU.0000417454.99685.13
,
Issn Print: 1742-8009
Publication Date: 2012/07/01
Facebook
Twitter
LinkedIn
Email
 |
Checking for direct PDF access through Ovid | |
Abstract
Abstract
A Phase III trial reported at the Meeting showed that olanzapine was effective in controlling breakthrough nausea and vomiting in patients on high doses of chemotherapy.
